

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.84816465 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.84816465 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.50220921 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.50220921 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.01575505 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.58893686 |
| 7 | bile acid biosynthetic process (GO:0006699) | 5.41207049 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.28292061 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.28292061 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.28292061 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.21666408 |
| 12 | negative regulation of fibrinolysis (GO:0051918) | 5.02504264 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.01449820 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 5.01350920 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.01096281 |
| 16 | tryptophan metabolic process (GO:0006568) | 4.95102720 |
| 17 | urea cycle (GO:0000050) | 4.87842378 |
| 18 | urea metabolic process (GO:0019627) | 4.87842378 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.85299572 |
| 20 | regulation of fibrinolysis (GO:0051917) | 4.83527104 |
| 21 | cysteine metabolic process (GO:0006534) | 4.75415115 |
| 22 | protein neddylation (GO:0045116) | 4.75254577 |
| 23 | complement activation, alternative pathway (GO:0006957) | 4.73769935 |
| 24 | regulation of protein activation cascade (GO:2000257) | 4.70416994 |
| 25 | bile acid metabolic process (GO:0008206) | 4.58243259 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.54594156 |
| 27 | protein carboxylation (GO:0018214) | 4.54594156 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.48242015 |
| 29 | cellular ketone body metabolic process (GO:0046950) | 4.44120457 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 4.40878562 |
| 31 | regulation of complement activation (GO:0030449) | 4.39748316 |
| 32 | tyrosine metabolic process (GO:0006570) | 4.39149810 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.36963545 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 4.32292499 |
| 35 | protein-lipid complex remodeling (GO:0034368) | 4.23549833 |
| 36 | macromolecular complex remodeling (GO:0034367) | 4.23549833 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.23549833 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 4.20550224 |
| 39 | coenzyme catabolic process (GO:0009109) | 4.17398907 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.11568918 |
| 41 | glutamate metabolic process (GO:0006536) | 4.09115311 |
| 42 | cellular glucuronidation (GO:0052695) | 4.08456463 |
| 43 | acylglycerol homeostasis (GO:0055090) | 4.07288118 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.07288118 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.06242572 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 4.06165471 |
| 47 | lysine catabolic process (GO:0006554) | 4.04700905 |
| 48 | lysine metabolic process (GO:0006553) | 4.04700905 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 4.04417759 |
| 50 | benzene-containing compound metabolic process (GO:0042537) | 4.01086660 |
| 51 | negative regulation of sterol transport (GO:0032372) | 3.97615399 |
| 52 | negative regulation of cholesterol transport (GO:0032375) | 3.97615399 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 3.94665728 |
| 54 | bile acid and bile salt transport (GO:0015721) | 3.93397998 |
| 55 | phospholipid efflux (GO:0033700) | 3.89473980 |
| 56 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.87806719 |
| 57 | drug catabolic process (GO:0042737) | 3.87016787 |
| 58 | indolalkylamine metabolic process (GO:0006586) | 3.85495633 |
| 59 | ketone body metabolic process (GO:1902224) | 3.84417752 |
| 60 | uronic acid metabolic process (GO:0006063) | 3.80873068 |
| 61 | glucuronate metabolic process (GO:0019585) | 3.80873068 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 3.80533740 |
| 63 | imidazole-containing compound metabolic process (GO:0052803) | 3.80031006 |
| 64 | cholesterol efflux (GO:0033344) | 3.72666448 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 3.69501138 |
| 66 | ethanol oxidation (GO:0006069) | 3.68834958 |
| 67 | cellular modified amino acid catabolic process (GO:0042219) | 3.68180451 |
| 68 | aldehyde catabolic process (GO:0046185) | 3.67039752 |
| 69 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.64769997 |
| 70 | amine catabolic process (GO:0009310) | 3.61903662 |
| 71 | cellular biogenic amine catabolic process (GO:0042402) | 3.61903662 |
| 72 | arginine metabolic process (GO:0006525) | 3.61391428 |
| 73 | nucleobase catabolic process (GO:0046113) | 3.51067402 |
| 74 | response to nitrosative stress (GO:0051409) | 3.50111784 |
| 75 | exogenous drug catabolic process (GO:0042738) | 3.49244658 |
| 76 | fibrinolysis (GO:0042730) | 3.47806828 |
| 77 | low-density lipoprotein particle remodeling (GO:0034374) | 3.46727976 |
| 78 | negative regulation of lipase activity (GO:0060192) | 3.46047492 |
| 79 | flavonoid metabolic process (GO:0009812) | 3.43562916 |
| 80 | cofactor catabolic process (GO:0051187) | 3.43054997 |
| 81 | regulation of bile acid biosynthetic process (GO:0070857) | 3.42135787 |
| 82 | cytolysis (GO:0019835) | 3.35529589 |
| 83 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.34093468 |
| 84 | short-chain fatty acid metabolic process (GO:0046459) | 3.33683535 |
| 85 | organic acid catabolic process (GO:0016054) | 3.31141571 |
| 86 | carboxylic acid catabolic process (GO:0046395) | 3.31141571 |
| 87 | epoxygenase P450 pathway (GO:0019373) | 3.31041127 |
| 88 | blood coagulation, intrinsic pathway (GO:0007597) | 3.30431854 |
| 89 | complement activation, classical pathway (GO:0006958) | 3.29086019 |
| 90 | serine family amino acid metabolic process (GO:0009069) | 3.28000944 |
| 91 | opsonization (GO:0008228) | 3.27932371 |
| 92 | plasma lipoprotein particle assembly (GO:0034377) | 3.27564043 |
| 93 | drug metabolic process (GO:0017144) | 3.23920598 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.23611570 |
| 95 | negative regulation of protein activation cascade (GO:2000258) | 3.23520207 |
| 96 | glycine metabolic process (GO:0006544) | 3.22708705 |
| 97 | complement activation (GO:0006956) | 3.22335343 |
| 98 | protein activation cascade (GO:0072376) | 3.19202951 |
| 99 | acetyl-CoA metabolic process (GO:0006084) | 3.18894624 |
| 100 | xenobiotic catabolic process (GO:0042178) | 3.18230693 |
| 101 | alkaloid metabolic process (GO:0009820) | 3.17965217 |
| 102 | negative regulation of norepinephrine secretion (GO:0010700) | 3.16306855 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.11135683 |
| 104 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.09362266 |
| 105 | L-serine metabolic process (GO:0006563) | 3.03390428 |
| 106 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.01983252 |
| 107 | fatty acid elongation (GO:0030497) | 2.99617800 |
| 108 | negative regulation of catecholamine secretion (GO:0033604) | 2.67054456 |
| 109 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.65513906 |
| 110 | beta-amyloid metabolic process (GO:0050435) | 2.62995176 |
| 111 | regulation of lipoprotein metabolic process (GO:0050746) | 2.60117122 |
| 112 | paraxial mesoderm development (GO:0048339) | 2.58385690 |
| 113 | polyamine biosynthetic process (GO:0006596) | 2.57579242 |
| 114 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.56286367 |
| 115 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.49726447 |
| 116 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.49640608 |
| 117 | linoleic acid metabolic process (GO:0043651) | 2.48404693 |
| 118 | lung-associated mesenchyme development (GO:0060484) | 2.45943590 |
| 119 | cholesterol biosynthetic process (GO:0006695) | 2.45680341 |
| 120 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.45540553 |
| 121 | midgut development (GO:0007494) | 2.40546011 |
| 122 | protein retention in ER lumen (GO:0006621) | 2.38759491 |
| 123 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.34976896 |
| 124 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.34195095 |
| 125 | positive regulation of hemostasis (GO:1900048) | 2.33605031 |
| 126 | positive regulation of blood coagulation (GO:0030194) | 2.33605031 |
| 127 | negative regulation of heart rate (GO:0010459) | 2.33449140 |
| 128 | platelet degranulation (GO:0002576) | 2.32822645 |
| 129 | serine family amino acid biosynthetic process (GO:0009070) | 2.31268862 |
| 130 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.30941999 |
| 131 | omega-hydroxylase P450 pathway (GO:0097267) | 2.30655288 |
| 132 | sterol biosynthetic process (GO:0016126) | 2.27766750 |
| 133 | negative regulation of blood coagulation (GO:0030195) | 2.26974580 |
| 134 | negative regulation of hemostasis (GO:1900047) | 2.26974580 |
| 135 | thrombin receptor signaling pathway (GO:0070493) | 2.25122241 |
| 136 | proline biosynthetic process (GO:0006561) | 2.24619698 |
| 137 | cyclooxygenase pathway (GO:0019371) | 2.23318925 |
| 138 | negative regulation of wound healing (GO:0061045) | 2.23215245 |
| 139 | anterior/posterior axis specification, embryo (GO:0008595) | 2.22898679 |
| 140 | proline metabolic process (GO:0006560) | 2.22172785 |
| 141 | protein maturation by protein folding (GO:0022417) | 2.22021026 |
| 142 | cellular response to prostaglandin stimulus (GO:0071379) | 2.19596816 |
| 143 | very long-chain fatty acid metabolic process (GO:0000038) | 2.18704074 |
| 144 | cerebellar granule cell differentiation (GO:0021707) | 2.18464671 |
| 145 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.17263793 |
| 146 | sequestering of actin monomers (GO:0042989) | 2.14740146 |
| 147 | androgen biosynthetic process (GO:0006702) | 2.14634086 |
| 148 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.14009012 |
| 149 | extracellular fibril organization (GO:0043206) | 2.13479139 |
| 150 | microtubule depolymerization (GO:0007019) | 2.13131931 |
| 151 | positive regulation of coagulation (GO:0050820) | 2.12563665 |
| 152 | negative regulation of microtubule polymerization (GO:0031115) | 2.09611018 |
| 153 | ethanol metabolic process (GO:0006067) | 2.08906643 |
| 154 | polyketide metabolic process (GO:0030638) | 2.08673631 |
| 155 | doxorubicin metabolic process (GO:0044598) | 2.08673631 |
| 156 | daunorubicin metabolic process (GO:0044597) | 2.08673631 |
| 157 | mating behavior (GO:0007617) | 2.07720958 |
| 158 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.06737765 |
| 159 | negative regulation of coagulation (GO:0050819) | 2.06388115 |
| 160 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.06220846 |
| 161 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.05702882 |
| 162 | triglyceride catabolic process (GO:0019433) | 2.05127181 |
| 163 | establishment of integrated proviral latency (GO:0075713) | 2.04798006 |
| 164 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.00997532 |
| 165 | presynaptic membrane assembly (GO:0097105) | 2.00173043 |
| 166 | myelination in peripheral nervous system (GO:0022011) | 1.99702746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.64683270 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.10033329 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.95331974 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.80712927 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.66251555 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.97177219 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.48046884 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.42230149 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.98967383 |
| 10 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.71877863 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.66266799 |
| 12 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.53115807 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.37072967 |
| 14 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.18402578 |
| 15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.10879144 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.01535536 |
| 17 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.85414404 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.82106812 |
| 19 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82022080 |
| 20 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.80896124 |
| 21 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.79101840 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.77289105 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.75021553 |
| 24 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.72525009 |
| 25 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.67853899 |
| 26 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.65300462 |
| 27 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.64557477 |
| 28 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.61992845 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.61342261 |
| 30 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.60686048 |
| 31 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.56754316 |
| 32 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.55388395 |
| 33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.54634272 |
| 34 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.48889584 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.48432774 |
| 36 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.48329037 |
| 37 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.45647830 |
| 38 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.44492213 |
| 39 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.43032607 |
| 40 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.40666862 |
| 41 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.40187069 |
| 42 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.39968288 |
| 43 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.38147316 |
| 44 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.37952673 |
| 45 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.34699837 |
| 46 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.33657747 |
| 47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.33524665 |
| 48 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.33470266 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32292258 |
| 50 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.31697988 |
| 51 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.28254210 |
| 52 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.26000755 |
| 53 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.25636359 |
| 54 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.25636359 |
| 55 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.24826613 |
| 56 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.23319311 |
| 57 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.22094528 |
| 58 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.21904199 |
| 59 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.20268424 |
| 60 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18697349 |
| 61 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18464224 |
| 62 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15764282 |
| 63 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.13118826 |
| 64 | * POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.12460660 |
| 65 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12400100 |
| 66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11101522 |
| 67 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.10297462 |
| 68 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.09926168 |
| 69 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.09513074 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08857146 |
| 71 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.08760527 |
| 72 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07231235 |
| 73 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07145341 |
| 74 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.06369656 |
| 75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04356078 |
| 76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04356078 |
| 77 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.03272357 |
| 78 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.03031627 |
| 79 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01501617 |
| 80 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.01165199 |
| 81 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00736775 |
| 82 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.00495449 |
| 83 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00052540 |
| 84 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.99530658 |
| 85 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99037572 |
| 86 | EWS_26573619_Chip-Seq_HEK293_Human | 0.98247844 |
| 87 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.96970722 |
| 88 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96883843 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96760985 |
| 90 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.96614095 |
| 91 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.96564761 |
| 92 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96258250 |
| 93 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.95790359 |
| 94 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.95684506 |
| 95 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.95393063 |
| 96 | FUS_26573619_Chip-Seq_HEK293_Human | 0.94985201 |
| 97 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93786335 |
| 98 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.93774531 |
| 99 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.93618195 |
| 100 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.93112855 |
| 101 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93104763 |
| 102 | * ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90942811 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90774656 |
| 104 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.90601695 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90311310 |
| 106 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.89686715 |
| 107 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.87916462 |
| 108 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87908452 |
| 109 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.87770268 |
| 110 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86621772 |
| 111 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.86602737 |
| 112 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.86442453 |
| 113 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.86209662 |
| 114 | JUN_21703547_ChIP-Seq_K562_Human | 0.85766123 |
| 115 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84860830 |
| 116 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84843339 |
| 117 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.84176006 |
| 118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83748025 |
| 119 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.82069040 |
| 120 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.81582953 |
| 121 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.81195918 |
| 122 | AR_25329375_ChIP-Seq_VCAP_Human | 0.80481376 |
| 123 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.79063332 |
| 124 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.78069669 |
| 125 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.76273193 |
| 126 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.74915819 |
| 127 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.74457344 |
| 128 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.74176494 |
| 129 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73936789 |
| 130 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.72006352 |
| 131 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.71011293 |
| 132 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.70923965 |
| 133 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.70159529 |
| 134 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.69561263 |
| 135 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.68742849 |
| 136 | VDR_22108803_ChIP-Seq_LS180_Human | 0.68593826 |
| 137 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.68113236 |
| 138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.68087645 |
| 139 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.67812625 |
| 140 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.67030077 |
| 141 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.67030077 |
| 142 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.66712786 |
| 143 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.66365320 |
| 144 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.66213218 |
| 145 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.66045144 |
| 146 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.65894184 |
| 147 | KDM2B_26808549_Chip-Seq_REH_Human | 0.65347675 |
| 148 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.65149718 |
| 149 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.65073137 |
| 150 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.64131926 |
| 151 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63835819 |
| 152 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.63369623 |
| 153 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.63034230 |
| 154 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.61495081 |
| 155 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.61101322 |
| 156 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.61058466 |
| 157 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.60413488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.64545151 |
| 2 | MP0005360_urolithiasis | 6.83847096 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.80243850 |
| 4 | MP0005365_abnormal_bile_salt | 5.67836972 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.13104175 |
| 6 | MP0003252_abnormal_bile_duct | 3.33998515 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.32639424 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.13891687 |
| 9 | MP0003195_calcinosis | 2.67374983 |
| 10 | MP0005083_abnormal_biliary_tract | 2.65434108 |
| 11 | MP0005332_abnormal_amino_acid | 2.52857884 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.26821022 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.22210932 |
| 14 | MP0009840_abnormal_foam_cell | 2.20779660 |
| 15 | MP0004272_abnormal_basement_membrane | 2.18922654 |
| 16 | MP0003941_abnormal_skin_development | 2.03932549 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 1.98734098 |
| 18 | MP0005187_abnormal_penis_morphology | 1.96527137 |
| 19 | MP0000566_synostosis | 1.88780689 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.86997300 |
| 21 | MP0003868_abnormal_feces_composition | 1.81345270 |
| 22 | MP0001188_hyperpigmentation | 1.79964157 |
| 23 | MP0010030_abnormal_orbit_morphology | 1.70975313 |
| 24 | MP0004270_analgesia | 1.65949146 |
| 25 | MP0000609_abnormal_liver_physiology | 1.65941261 |
| 26 | MP0008004_abnormal_stomach_pH | 1.63987846 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 1.59977502 |
| 28 | MP0005623_abnormal_meninges_morphology | 1.56290052 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.55868722 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.52928786 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.47550791 |
| 32 | MP0008932_abnormal_embryonic_tissue | 1.47282812 |
| 33 | MP0000778_abnormal_nervous_system | 1.47115739 |
| 34 | MP0003937_abnormal_limbs/digits/tail_de | 1.46001891 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.45233762 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.44884062 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.44674446 |
| 38 | MP0003880_abnormal_central_pattern | 1.41873730 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.39511355 |
| 40 | MP0001299_abnormal_eye_distance/ | 1.38794345 |
| 41 | MP0001764_abnormal_homeostasis | 1.37997252 |
| 42 | MP0009697_abnormal_copulation | 1.36498968 |
| 43 | MP0002822_catalepsy | 1.34386349 |
| 44 | MP0003123_paternal_imprinting | 1.33576063 |
| 45 | MP0003329_amyloid_beta_deposits | 1.33448362 |
| 46 | MP0009672_abnormal_birth_weight | 1.32028235 |
| 47 | MP0003942_abnormal_urinary_system | 1.31035161 |
| 48 | MP0002697_abnormal_eye_size | 1.28356694 |
| 49 | MP0003121_genomic_imprinting | 1.27094951 |
| 50 | MP0000604_amyloidosis | 1.24340728 |
| 51 | MP0000049_abnormal_middle_ear | 1.24062672 |
| 52 | MP0004859_abnormal_synaptic_plasticity | 1.22359435 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 1.22116575 |
| 54 | MP0000537_abnormal_urethra_morphology | 1.21364923 |
| 55 | MP0001293_anophthalmia | 1.21242503 |
| 56 | MP0002233_abnormal_nose_morphology | 1.17487677 |
| 57 | MP0003119_abnormal_digestive_system | 1.17266901 |
| 58 | MP0000579_abnormal_nail_morphology | 1.15429523 |
| 59 | MP0005670_abnormal_white_adipose | 1.14531990 |
| 60 | MP0001984_abnormal_olfaction | 1.13326108 |
| 61 | MP0002249_abnormal_larynx_morphology | 1.08339722 |
| 62 | MP0003635_abnormal_synaptic_transmissio | 1.07971031 |
| 63 | MP0002254_reproductive_system_inflammat | 1.07375577 |
| 64 | MP0005535_abnormal_body_temperature | 1.06156700 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 1.05571606 |
| 66 | MP0009745_abnormal_behavioral_response | 1.02414840 |
| 67 | MP0000647_abnormal_sebaceous_gland | 1.02346922 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.01808118 |
| 69 | MP0002063_abnormal_learning/memory/cond | 1.01253896 |
| 70 | MP0003011_delayed_dark_adaptation | 1.00999549 |
| 71 | MP0003718_maternal_effect | 0.99962793 |
| 72 | MP0000534_abnormal_ureter_morphology | 0.99827848 |
| 73 | MP0009643_abnormal_urine_homeostasis | 0.96939544 |
| 74 | MP0001501_abnormal_sleep_pattern | 0.94520832 |
| 75 | MP0002102_abnormal_ear_morphology | 0.94369312 |
| 76 | MP0003861_abnormal_nervous_system | 0.93615537 |
| 77 | MP0005503_abnormal_tendon_morphology | 0.93335187 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 0.93291744 |
| 79 | MP0001849_ear_inflammation | 0.93073606 |
| 80 | MP0002909_abnormal_adrenal_gland | 0.90911332 |
| 81 | MP0002064_seizures | 0.90328485 |
| 82 | MP0005275_abnormal_skin_tensile | 0.90093137 |
| 83 | MP0005647_abnormal_sex_gland | 0.89591635 |
| 84 | MP0003315_abnormal_perineum_morphology | 0.89304294 |
| 85 | MP0001440_abnormal_grooming_behavior | 0.89056291 |
| 86 | MP0005501_abnormal_skin_physiology | 0.88102089 |
| 87 | MP0002078_abnormal_glucose_homeostasis | 0.87979464 |
| 88 | MP0008872_abnormal_physiological_respon | 0.87717944 |
| 89 | MP0002653_abnormal_ependyma_morphology | 0.87348733 |
| 90 | MP0004133_heterotaxia | 0.86205644 |
| 91 | MP0000428_abnormal_craniofacial_morphol | 0.84683389 |
| 92 | MP0005394_taste/olfaction_phenotype | 0.84594099 |
| 93 | MP0005499_abnormal_olfactory_system | 0.84594099 |
| 94 | MP0002572_abnormal_emotion/affect_behav | 0.84500673 |
| 95 | MP0001968_abnormal_touch/_nociception | 0.84255720 |
| 96 | MP0003890_abnormal_embryonic-extraembry | 0.82721712 |
| 97 | MP0004811_abnormal_neuron_physiology | 0.82719700 |
| 98 | MP0000598_abnormal_liver_morphology | 0.81214093 |
| 99 | MP0006054_spinal_hemorrhage | 0.80780547 |
| 100 | MP0006292_abnormal_olfactory_placode | 0.80649260 |
| 101 | MP0005257_abnormal_intraocular_pressure | 0.79502698 |
| 102 | MP0002092_abnormal_eye_morphology | 0.78955906 |
| 103 | MP0001905_abnormal_dopamine_level | 0.78866727 |
| 104 | MP0003186_abnormal_redox_activity | 0.78777014 |
| 105 | MP0001286_abnormal_eye_development | 0.78113886 |
| 106 | MP0009384_cardiac_valve_regurgitation | 0.77959516 |
| 107 | MP0000639_abnormal_adrenal_gland | 0.77770547 |
| 108 | MP0009703_decreased_birth_body | 0.77741622 |
| 109 | MP0005448_abnormal_energy_balance | 0.77668308 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.77112322 |
| 111 | MP0002084_abnormal_developmental_patter | 0.75644198 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.75539503 |
| 113 | MP0003283_abnormal_digestive_organ | 0.75269240 |
| 114 | MP0009642_abnormal_blood_homeostasis | 0.74678561 |
| 115 | MP0003385_abnormal_body_wall | 0.74535060 |
| 116 | MP0004957_abnormal_blastocyst_morpholog | 0.74187146 |
| 117 | MP0002938_white_spotting | 0.73655552 |
| 118 | MP0009780_abnormal_chondrocyte_physiolo | 0.73580127 |
| 119 | MP0009053_abnormal_anal_canal | 0.73439820 |
| 120 | MP0003755_abnormal_palate_morphology | 0.73013005 |
| 121 | MP0001177_atelectasis | 0.72743436 |
| 122 | MP0003690_abnormal_glial_cell | 0.72612649 |
| 123 | MP0008874_decreased_physiological_sensi | 0.71986938 |
| 124 | MP0002111_abnormal_tail_morphology | 0.70935322 |
| 125 | MP0002090_abnormal_vision | 0.70443584 |
| 126 | MP0002736_abnormal_nociception_after | 0.69853949 |
| 127 | MP0005451_abnormal_body_composition | 0.69620573 |
| 128 | MP0010368_abnormal_lymphatic_system | 0.69426660 |
| 129 | MP0005646_abnormal_pituitary_gland | 0.66531865 |
| 130 | MP0009379_abnormal_foot_pigmentation | 0.65981820 |
| 131 | MP0009764_decreased_sensitivity_to | 0.65856821 |
| 132 | MP0002069_abnormal_eating/drinking_beha | 0.65097925 |
| 133 | MP0004043_abnormal_pH_regulation | 0.65048831 |
| 134 | MP0002735_abnormal_chemical_nociception | 0.64915390 |
| 135 | MP0005334_abnormal_fat_pad | 0.64897758 |
| 136 | MP0003879_abnormal_hair_cell | 0.64096229 |
| 137 | MP0003656_abnormal_erythrocyte_physiolo | 0.64022571 |
| 138 | MP0006036_abnormal_mitochondrial_physio | 0.63891695 |
| 139 | MP0003953_abnormal_hormone_level | 0.63802278 |
| 140 | MP0001756_abnormal_urination | 0.63273345 |
| 141 | MP0000538_abnormal_urinary_bladder | 0.62576572 |
| 142 | MP0002971_abnormal_brown_adipose | 0.62460131 |
| 143 | MP0001529_abnormal_vocalization | 0.62092944 |
| 144 | MP0005220_abnormal_exocrine_pancreas | 0.61892862 |
| 145 | MP0006035_abnormal_mitochondrial_morpho | 0.61451632 |
| 146 | MP0003122_maternal_imprinting | 0.61129272 |
| 147 | MP0005248_abnormal_Harderian_gland | 0.60837254 |
| 148 | MP0005645_abnormal_hypothalamus_physiol | 0.60684451 |
| 149 | MP0004130_abnormal_muscle_cell | 0.59976674 |
| 150 | MP0002734_abnormal_mechanical_nocicepti | 0.59567028 |
| 151 | MP0009765_abnormal_xenobiotic_induced | 0.59235624 |
| 152 | MP0002272_abnormal_nervous_system | 0.58788835 |
| 153 | MP0010234_abnormal_vibrissa_follicle | 0.58420325 |
| 154 | MP0009763_increased_sensitivity_to | 0.58150613 |
| 155 | MP0005266_abnormal_metabolism | 0.57494230 |
| 156 | MP0002733_abnormal_thermal_nociception | 0.55797643 |
| 157 | MP0003638_abnormal_response/metabolism_ | 0.54998739 |
| 158 | MP0003959_abnormal_lean_body | 0.53829227 |
| 159 | MP0002557_abnormal_social/conspecific_i | 0.53322557 |
| 160 | MP0005551_abnormal_eye_electrophysiolog | 0.52037859 |
| 161 | MP0004924_abnormal_behavior | 0.51644464 |
| 162 | MP0005386_behavior/neurological_phenoty | 0.51644464 |
| 163 | MP0000230_abnormal_systemic_arterial | 0.51471125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.84611228 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.65017694 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.27553440 |
| 4 | Increased mean platelet volume (HP:0011877) | 6.07557150 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.07326800 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.75095382 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.70477347 |
| 8 | Xanthomatosis (HP:0000991) | 5.50756789 |
| 9 | Abnormal platelet volume (HP:0011876) | 5.21721180 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.95348660 |
| 11 | Complement deficiency (HP:0004431) | 4.89336832 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.26353235 |
| 13 | Epidermoid cyst (HP:0200040) | 4.07032614 |
| 14 | Ketosis (HP:0001946) | 4.04259206 |
| 15 | Purpura (HP:0000979) | 3.99311037 |
| 16 | Hyperglycinemia (HP:0002154) | 3.92060211 |
| 17 | Joint hemorrhage (HP:0005261) | 3.91189595 |
| 18 | Hyperammonemia (HP:0001987) | 3.85837564 |
| 19 | Hepatoblastoma (HP:0002884) | 3.84528725 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.83351368 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.83047028 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.73024512 |
| 23 | Fat malabsorption (HP:0002630) | 3.65605911 |
| 24 | Conjugated hyperbilirubinemia (HP:0002908) | 3.55419013 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.45627969 |
| 26 | Prolonged bleeding time (HP:0003010) | 3.41850360 |
| 27 | Abnormality of complement system (HP:0005339) | 3.40560819 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.38105717 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.36738748 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.34474417 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.34474417 |
| 32 | Abnormality of methionine metabolism (HP:0010901) | 3.31081746 |
| 33 | Hyperglycinuria (HP:0003108) | 3.25022584 |
| 34 | Enlarged kidneys (HP:0000105) | 3.23854445 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 3.23672726 |
| 36 | Ketoacidosis (HP:0001993) | 3.19699295 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.11832592 |
| 38 | Petechiae (HP:0000967) | 3.07752256 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.03710193 |
| 40 | Neonatal hypoglycemia (HP:0001998) | 3.01528441 |
| 41 | Hypoglycemic coma (HP:0001325) | 3.00224680 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.88376505 |
| 43 | Spontaneous abortion (HP:0005268) | 2.88305542 |
| 44 | Hyperbilirubinemia (HP:0002904) | 2.84155668 |
| 45 | Skin nodule (HP:0200036) | 2.76641572 |
| 46 | Gout (HP:0001997) | 2.76250697 |
| 47 | Polyphagia (HP:0002591) | 2.74869640 |
| 48 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.70987014 |
| 49 | Myokymia (HP:0002411) | 2.69519295 |
| 50 | Abnormal gallbladder physiology (HP:0012438) | 2.69049914 |
| 51 | Cholecystitis (HP:0001082) | 2.69049914 |
| 52 | Back pain (HP:0003418) | 2.65475446 |
| 53 | Steatorrhea (HP:0002570) | 2.61907340 |
| 54 | Long foot (HP:0001833) | 2.61877455 |
| 55 | Termporal pattern (HP:0011008) | 2.60228615 |
| 56 | Insidious onset (HP:0003587) | 2.60228615 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.59817486 |
| 58 | Cortical dysplasia (HP:0002539) | 2.57667092 |
| 59 | Abnormality of nucleobase metabolism (HP:0010932) | 2.56979174 |
| 60 | Abnormality of serum amino acid levels (HP:0003112) | 2.55606773 |
| 61 | Metabolic acidosis (HP:0001942) | 2.47665108 |
| 62 | Neonatal onset (HP:0003623) | 2.47547824 |
| 63 | Abnormality of purine metabolism (HP:0004352) | 2.41280508 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.40876216 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.39990269 |
| 66 | Cerebral edema (HP:0002181) | 2.38707420 |
| 67 | Lethargy (HP:0001254) | 2.37115601 |
| 68 | Brushfield spots (HP:0001088) | 2.36799375 |
| 69 | Diastasis recti (HP:0001540) | 2.35838343 |
| 70 | Sensorimotor neuropathy (HP:0007141) | 2.34477364 |
| 71 | Abnormal gallbladder morphology (HP:0012437) | 2.33849673 |
| 72 | Irritability (HP:0000737) | 2.32099008 |
| 73 | Status epilepticus (HP:0002133) | 2.31551493 |
| 74 | Coronal craniosynostosis (HP:0004440) | 2.31474513 |
| 75 | Acanthocytosis (HP:0001927) | 2.31080588 |
| 76 | Hypoglycemic seizures (HP:0002173) | 2.28313347 |
| 77 | Cholelithiasis (HP:0001081) | 2.26845923 |
| 78 | Premature rupture of membranes (HP:0001788) | 2.24517422 |
| 79 | Hyperventilation (HP:0002883) | 2.22643359 |
| 80 | Vascular calcification (HP:0004934) | 2.18974609 |
| 81 | Mitral stenosis (HP:0001718) | 2.18032479 |
| 82 | Gingival bleeding (HP:0000225) | 2.16988392 |
| 83 | Amyloidosis (HP:0011034) | 2.15546195 |
| 84 | Limb dystonia (HP:0002451) | 2.14112987 |
| 85 | Spastic diplegia (HP:0001264) | 2.13866234 |
| 86 | Neoplasm of the adrenal cortex (HP:0100641) | 2.12763580 |
| 87 | Systemic lupus erythematosus (HP:0002725) | 2.09178897 |
| 88 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.08429481 |
| 89 | Malnutrition (HP:0004395) | 2.03495466 |
| 90 | Abnormal pancreas size (HP:0012094) | 2.03286589 |
| 91 | Impaired platelet aggregation (HP:0003540) | 2.00233305 |
| 92 | Abnormal platelet function (HP:0011869) | 2.00233305 |
| 93 | Turricephaly (HP:0000262) | 1.96192547 |
| 94 | Cardiovascular calcification (HP:0011915) | 1.94507507 |
| 95 | Glomerulonephritis (HP:0000099) | 1.93929339 |
| 96 | Late onset (HP:0003584) | 1.93746716 |
| 97 | Craniofacial dystonia (HP:0012179) | 1.93524244 |
| 98 | Abnormality of the gallbladder (HP:0005264) | 1.93470739 |
| 99 | Torticollis (HP:0000473) | 1.92552888 |
| 100 | Vomiting (HP:0002013) | 1.92389580 |
| 101 | Myocardial infarction (HP:0001658) | 1.90902492 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 1.87049688 |
| 103 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.87049688 |
| 104 | Cerebral inclusion bodies (HP:0100314) | 1.84662786 |
| 105 | Neoplasm of the adrenal gland (HP:0100631) | 1.84270244 |
| 106 | Focal dystonia (HP:0004373) | 1.84073644 |
| 107 | Hydroxyprolinuria (HP:0003080) | 1.84053000 |
| 108 | Abnormality of proline metabolism (HP:0010907) | 1.84053000 |
| 109 | Neurofibrillary tangles (HP:0002185) | 1.82327029 |
| 110 | Protrusio acetabuli (HP:0003179) | 1.80605582 |
| 111 | Upper limb muscle weakness (HP:0003484) | 1.80372222 |
| 112 | Menorrhagia (HP:0000132) | 1.79969007 |
| 113 | Epistaxis (HP:0000421) | 1.79961970 |
| 114 | Delayed myelination (HP:0012448) | 1.78650334 |
| 115 | Poor suck (HP:0002033) | 1.78528690 |
| 116 | Split foot (HP:0001839) | 1.78181273 |
| 117 | Aplasia involving bones of the extremities (HP:0009825) | 1.77804205 |
| 118 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.77804205 |
| 119 | Aplasia of the phalanges of the hand (HP:0009802) | 1.77804205 |
| 120 | Alkalosis (HP:0001948) | 1.77330897 |
| 121 | Opisthotonus (HP:0002179) | 1.77140642 |
| 122 | Pancreatitis (HP:0001733) | 1.76971949 |
| 123 | Rickets (HP:0002748) | 1.76069521 |
| 124 | Generalized hypotonia (HP:0001290) | 1.73667993 |
| 125 | Confusion (HP:0001289) | 1.72847249 |
| 126 | Abnormality of vitamin metabolism (HP:0100508) | 1.72431710 |
| 127 | Osteomalacia (HP:0002749) | 1.71827726 |
| 128 | Abnormality of the corticospinal tract (HP:0002492) | 1.70609604 |
| 129 | Hypophosphatemic rickets (HP:0004912) | 1.68773362 |
| 130 | Abnormality of dentin (HP:0010299) | 1.68729038 |
| 131 | Urinary urgency (HP:0000012) | 1.67838509 |
| 132 | Increased purine levels (HP:0004368) | 1.67439138 |
| 133 | Myelomeningocele (HP:0002475) | 1.67401136 |
| 134 | Bifid scrotum (HP:0000048) | 1.67193782 |
| 135 | Choanal stenosis (HP:0000452) | 1.66467053 |
| 136 | Abnormality of the labia minora (HP:0012880) | 1.64982520 |
| 137 | Abnormal eating behavior (HP:0100738) | 1.64065807 |
| 138 | Abnormality of the Achilles tendon (HP:0005109) | 1.59810816 |
| 139 | Impaired pain sensation (HP:0007328) | 1.56034793 |
| 140 | Abnormality of pain sensation (HP:0010832) | 1.56034793 |
| 141 | Partial duplication of thumb phalanx (HP:0009944) | 1.54845365 |
| 142 | Ankle contracture (HP:0006466) | 1.54669972 |
| 143 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.54542089 |
| 144 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.54542089 |
| 145 | Sleep apnea (HP:0010535) | 1.53903113 |
| 146 | Partial duplication of the phalanx of hand (HP:0009999) | 1.53349106 |
| 147 | Poikilocytosis (HP:0004447) | 1.53129934 |
| 148 | Failure to thrive in infancy (HP:0001531) | 1.52463020 |
| 149 | Papillary thyroid carcinoma (HP:0002895) | 1.51382777 |
| 150 | Decreased muscle mass (HP:0003199) | 1.51178431 |
| 151 | Abnormality of the diencephalon (HP:0010662) | 1.49750849 |
| 152 | Abnormal delivery (HP:0001787) | 1.48020794 |
| 153 | Bifid tongue (HP:0010297) | 1.47631598 |
| 154 | Humeroradial synostosis (HP:0003041) | 1.46581317 |
| 155 | Synostosis involving the elbow (HP:0003938) | 1.46581317 |
| 156 | Broad metatarsal (HP:0001783) | 1.45051325 |
| 157 | Spastic gait (HP:0002064) | 1.43821873 |
| 158 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.43039357 |
| 159 | Dyschromatopsia (HP:0007641) | 1.42918303 |
| 160 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.42354367 |
| 161 | Hypoventilation (HP:0002791) | 1.41369394 |
| 162 | Labial hypoplasia (HP:0000066) | 1.39879451 |
| 163 | Conjunctival telangiectasia (HP:0000524) | 1.39461858 |
| 164 | Abnormal pupillary function (HP:0007686) | 1.39290262 |
| 165 | Absent eyelashes (HP:0000561) | 1.39098228 |
| 166 | Drooling (HP:0002307) | 1.39058208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.83896917 |
| 2 | MAP2K4 | 2.97419557 |
| 3 | EPHA4 | 2.86079997 |
| 4 | MARK1 | 2.66060815 |
| 5 | STK16 | 2.64079457 |
| 6 | MAP3K12 | 2.59132296 |
| 7 | MAP3K9 | 2.55813431 |
| 8 | SIK1 | 2.49862794 |
| 9 | FGFR4 | 2.42374423 |
| 10 | NTRK3 | 2.42182116 |
| 11 | DAPK2 | 2.33214270 |
| 12 | MAP3K4 | 2.18522157 |
| 13 | BMX | 2.16014589 |
| 14 | EIF2AK1 | 2.14620874 |
| 15 | DYRK2 | 2.08785814 |
| 16 | MINK1 | 2.05434085 |
| 17 | INSRR | 1.90936866 |
| 18 | ERBB4 | 1.86723232 |
| 19 | PRKG2 | 1.86220656 |
| 20 | ERN1 | 1.84331562 |
| 21 | MST4 | 1.82384053 |
| 22 | TRIM28 | 1.77085582 |
| 23 | MAP2K7 | 1.71934706 |
| 24 | TNIK | 1.69621671 |
| 25 | BRSK2 | 1.67453387 |
| 26 | CDC7 | 1.65642124 |
| 27 | CAMK2G | 1.54293114 |
| 28 | KSR1 | 1.51662188 |
| 29 | DYRK3 | 1.51235483 |
| 30 | FRK | 1.47023618 |
| 31 | CAMK2B | 1.46506587 |
| 32 | WEE1 | 1.46346370 |
| 33 | TTK | 1.42164818 |
| 34 | ARAF | 1.40644055 |
| 35 | TESK1 | 1.37344708 |
| 36 | NTRK2 | 1.36218577 |
| 37 | KSR2 | 1.35294538 |
| 38 | SIK2 | 1.32897988 |
| 39 | CDK14 | 1.31683102 |
| 40 | RIPK1 | 1.31631848 |
| 41 | SRPK1 | 1.30112420 |
| 42 | PLK3 | 1.24771430 |
| 43 | FGFR2 | 1.23711565 |
| 44 | MST1R | 1.22501399 |
| 45 | DAPK1 | 1.21946514 |
| 46 | PAK3 | 1.21362979 |
| 47 | WNK3 | 1.21327489 |
| 48 | SIK3 | 1.20821348 |
| 49 | PIK3CG | 1.19842596 |
| 50 | MAP3K2 | 1.19615047 |
| 51 | BRSK1 | 1.15944495 |
| 52 | CDK18 | 1.14317854 |
| 53 | MAPK15 | 1.14063176 |
| 54 | PRKCG | 1.13962341 |
| 55 | LATS2 | 1.13720194 |
| 56 | PBK | 1.13182534 |
| 57 | CASK | 1.13063997 |
| 58 | TAOK3 | 1.11532054 |
| 59 | NTRK1 | 1.10767304 |
| 60 | BUB1 | 1.10633996 |
| 61 | CDK15 | 1.10260090 |
| 62 | LIMK1 | 1.07949079 |
| 63 | MYLK | 1.07060106 |
| 64 | FER | 1.06874455 |
| 65 | ILK | 1.06314976 |
| 66 | GRK5 | 1.05847810 |
| 67 | MAP2K1 | 1.04237953 |
| 68 | CAMKK2 | 1.03963784 |
| 69 | CAMK2A | 1.03519384 |
| 70 | CDK11A | 0.99495390 |
| 71 | PAK6 | 0.99401544 |
| 72 | CAMK2D | 0.99207854 |
| 73 | CAMKK1 | 0.99058114 |
| 74 | PDGFRA | 0.98106626 |
| 75 | CSNK1A1L | 0.95858868 |
| 76 | PRKCZ | 0.94990502 |
| 77 | CAMK1D | 0.93208306 |
| 78 | MAP3K13 | 0.92108737 |
| 79 | PAK4 | 0.88494646 |
| 80 | CAMK1G | 0.88149565 |
| 81 | MKNK1 | 0.87427973 |
| 82 | CSNK1G2 | 0.85714504 |
| 83 | PAK1 | 0.83379240 |
| 84 | STK3 | 0.82107801 |
| 85 | DDR2 | 0.80152966 |
| 86 | AURKA | 0.79568823 |
| 87 | TSSK6 | 0.77729068 |
| 88 | NEK1 | 0.77472301 |
| 89 | ABL2 | 0.77327644 |
| 90 | DAPK3 | 0.77305460 |
| 91 | RET | 0.74769309 |
| 92 | PINK1 | 0.72179095 |
| 93 | BCR | 0.71837304 |
| 94 | PRKACG | 0.71708143 |
| 95 | CDK5 | 0.70712369 |
| 96 | PLK1 | 0.69159505 |
| 97 | MAPK4 | 0.68551825 |
| 98 | SGK223 | 0.68528697 |
| 99 | SGK494 | 0.68528697 |
| 100 | GRK6 | 0.63347725 |
| 101 | PRKCE | 0.60905670 |
| 102 | PHKG1 | 0.60814794 |
| 103 | PHKG2 | 0.60814794 |
| 104 | LATS1 | 0.59577384 |
| 105 | CSNK1G3 | 0.59042550 |
| 106 | MET | 0.58868008 |
| 107 | EPHA3 | 0.58117203 |
| 108 | CDK19 | 0.55169304 |
| 109 | RPS6KA4 | 0.54793502 |
| 110 | EPHB2 | 0.54646860 |
| 111 | ERBB2 | 0.54598095 |
| 112 | PAK2 | 0.53304062 |
| 113 | DYRK1A | 0.53109047 |
| 114 | PTK2 | 0.52686056 |
| 115 | SGK2 | 0.52584920 |
| 116 | CSNK1G1 | 0.52284692 |
| 117 | MAPK11 | 0.51345565 |
| 118 | UHMK1 | 0.50507799 |
| 119 | * CSNK1E | 0.49058149 |
| 120 | STK24 | 0.48990268 |
| 121 | TYRO3 | 0.48232515 |
| 122 | DMPK | 0.47838104 |
| 123 | MAP2K6 | 0.47272255 |
| 124 | MKNK2 | 0.46895522 |
| 125 | MAP3K6 | 0.46673571 |
| 126 | EPHA2 | 0.46563895 |
| 127 | ERBB3 | 0.45839462 |
| 128 | LMTK2 | 0.45744217 |
| 129 | MAP3K1 | 0.45413086 |
| 130 | MAP3K5 | 0.45061436 |
| 131 | BRAF | 0.44751227 |
| 132 | PTK2B | 0.43337412 |
| 133 | PLK2 | 0.42784844 |
| 134 | AKT2 | 0.42768507 |
| 135 | OXSR1 | 0.42715201 |
| 136 | STK38L | 0.42314376 |
| 137 | TAOK2 | 0.42072690 |
| 138 | PRKCA | 0.41550368 |
| 139 | PRKACA | 0.41094579 |
| 140 | JAK2 | 0.40540059 |
| 141 | CHEK2 | 0.40317850 |
| 142 | MAPK13 | 0.40264638 |
| 143 | ADRBK1 | 0.40227448 |
| 144 | PTK6 | 0.39715995 |
| 145 | CAMK4 | 0.37757026 |
| 146 | CAMK1 | 0.37140739 |
| 147 | MAP3K7 | 0.36671356 |
| 148 | DYRK1B | 0.36265655 |
| 149 | WNK4 | 0.36252752 |
| 150 | PDPK1 | 0.35442598 |
| 151 | PNCK | 0.34569854 |
| 152 | MAPK12 | 0.34046262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.29569351 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.33368903 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29563320 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.29292244 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89450487 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.63955765 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51994657 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.45786235 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.37421136 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.36672319 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.24437398 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.17689280 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.17389101 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15620181 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.06185369 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.02870686 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.01656996 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91367415 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.89189432 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.85007996 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76294733 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73679795 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70846241 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69988730 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.64505012 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.60569841 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.58002258 |
| 28 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57740966 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.56035722 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.55231383 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.55048171 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.50984071 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43494313 |
| 34 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43305809 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41399201 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39866593 |
| 37 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.39441714 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.30890178 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29823632 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25607982 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25556995 |
| 42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.25211482 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.22576884 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.19623881 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10734916 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.09147334 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07663392 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05895534 |
| 49 | Mismatch repair_Homo sapiens_hsa03430 | 1.05665790 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03557596 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 0.98043452 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97831753 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95422373 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.92998979 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91965972 |
| 56 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.91102817 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81889447 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78318262 |
| 59 | Nicotine addiction_Homo sapiens_hsa05033 | 0.76860423 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74943956 |
| 61 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.73915785 |
| 62 | Alcoholism_Homo sapiens_hsa05034 | 0.73845390 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70089416 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68139056 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67766986 |
| 66 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67509546 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.66560282 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65369322 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64329658 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63720402 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63269762 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.63021201 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62234422 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.62105190 |
| 75 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.61868517 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.58276812 |
| 77 | GABAergic synapse_Homo sapiens_hsa04727 | 0.57039432 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56649745 |
| 79 | Tight junction_Homo sapiens_hsa04530 | 0.55347077 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53737606 |
| 81 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53602504 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53483149 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51679148 |
| 84 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.51623286 |
| 85 | Axon guidance_Homo sapiens_hsa04360 | 0.49838989 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.46356498 |
| 87 | DNA replication_Homo sapiens_hsa03030 | 0.46211233 |
| 88 | Cell cycle_Homo sapiens_hsa04110 | 0.44555286 |
| 89 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42184496 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41951780 |
| 91 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.41749223 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40472833 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39897397 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39680076 |
| 95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.36589513 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36145997 |
| 97 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32605685 |
| 98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31437111 |
| 99 | Insulin secretion_Homo sapiens_hsa04911 | 0.28700482 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.28036971 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.27586245 |
| 102 | Renin secretion_Homo sapiens_hsa04924 | 0.24766801 |
| 103 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.24669848 |
| 104 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.22711766 |
| 105 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.22263715 |
| 106 | Circadian entrainment_Homo sapiens_hsa04713 | 0.20795943 |
| 107 | Cocaine addiction_Homo sapiens_hsa05030 | 0.19287496 |
| 108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19230362 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18992759 |
| 110 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.18385790 |
| 111 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.18091941 |
| 112 | Salivary secretion_Homo sapiens_hsa04970 | 0.17919724 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17599327 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.17408230 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14969532 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.12882106 |
| 117 | Morphine addiction_Homo sapiens_hsa05032 | 0.12290047 |
| 118 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.12074036 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.11986712 |
| 120 | Taste transduction_Homo sapiens_hsa04742 | 0.11314347 |
| 121 | Alzheimers disease_Homo sapiens_hsa05010 | 0.10209112 |
| 122 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.09359160 |
| 123 | Long-term potentiation_Homo sapiens_hsa04720 | 0.08861916 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.07955187 |

